These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 11129301)

  • 21. Revisiting the relapse predictive validity of prodromal symptoms in schizophrenia.
    Gaebel W; Riesbeck M
    Schizophr Res; 2007 Sep; 95(1-3):19-29. PubMed ID: 17630253
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Trajectories and antecedents of treatment response over time in early-episode psychosis.
    Levine SZ; Rabinowitz J
    Schizophr Bull; 2010 May; 36(3):624-32. PubMed ID: 18849294
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The relationship of premorbid functioning to illness course in schizophrenia and psychotic mood disorders during two years following first hospitalization.
    Haim R; Rabinowitz J; Bromet E
    J Nerv Ment Dis; 2006 Oct; 194(10):791-5. PubMed ID: 17041293
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The inter-rater and test-retest reliabilities of prodromal symptoms in first-episode psychosis.
    Jackson HJ; McGorry PD; Dakis J; Harrigan S; Henry L; Mihalopoulos C
    Aust N Z J Psychiatry; 1996 Aug; 30(4):498-504. PubMed ID: 8887700
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adult outcomes of child- and adolescent-onset schizophrenia: diagnostic stability and predictive validity.
    Hollis C
    Am J Psychiatry; 2000 Oct; 157(10):1652-9. PubMed ID: 11007720
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnostic validity of the Eppendorf Schizophrenia Inventory (ESI): a self-report screen for ultrahigh risk and acute psychosis.
    Niessen MA; Dingemans PM; van de Fliert R; Becker HE; Nieman DH; Linszen D
    Psychol Assess; 2010 Dec; 22(4):935-44. PubMed ID: 21133552
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [How far is psychopathology still meaningful for the treatment of schizophrenia?].
    Huber G
    Fortschr Neurol Psychiatr; 2001 Sep; 69 Suppl 2():S86-91. PubMed ID: 11533856
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Assessment of mental states at risk of psychotic transition: validation of the French version of the CAARMS].
    Krebs MO; Magaud E; Willard D; Elkhazen C; Chauchot F; Gut A; Morvan Y; Bourdel MC; Kazes M
    Encephale; 2014 Dec; 40(6):447-56. PubMed ID: 25127895
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Schizophrenia Cognition Rating Scale: an interview-based assessment and its relationship to cognition, real-world functioning, and functional capacity.
    Keefe RS; Poe M; Walker TM; Kang JW; Harvey PD
    Am J Psychiatry; 2006 Mar; 163(3):426-32. PubMed ID: 16513863
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Basic symptoms in schizophrenia, their clinical study and relevance in research].
    Miret S; Fatjó-Vilas M; Peralta V; Fañanás L
    Rev Psiquiatr Salud Ment; 2016; 9(2):111-22. PubMed ID: 26774677
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mismatch negativity deficits are associated with poor functioning in schizophrenia patients.
    Light GA; Braff DL
    Arch Gen Psychiatry; 2005 Feb; 62(2):127-36. PubMed ID: 15699289
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Evaluation of functional remission in schizophrenic disorder. The FROGS Scale].
    Rouillon F; Baylé FJ; Gorwood P; Lancrenon S; Lançon C; Llorca PM;
    Encephale; 2013 May; 39 Suppl 1():S15-21. PubMed ID: 23541143
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Premorbid personality indicators of schizophrenia-related psychosis in a hypothetically psychosis-prone college sample.
    Bolinskey PK; Gottesman II
    Scand J Psychol; 2010 Feb; 51(1):68-74. PubMed ID: 19497029
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Issues in selection of instruments to measure negative symptoms.
    Daniel DG
    Schizophr Res; 2013 Nov; 150(2-3):343-5. PubMed ID: 23899996
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diazepam treatment of early signs of exacerbation in schizophrenia.
    Carpenter WT; Buchanan RW; Kirkpatrick B; Breier AF
    Am J Psychiatry; 1999 Feb; 156(2):299-303. PubMed ID: 9989567
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The initial prodrome in psychosis: descriptive and qualitative aspects.
    Yung AR; McGorry PD
    Aust N Z J Psychiatry; 1996 Oct; 30(5):587-99. PubMed ID: 8902166
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Depression scales in schizophrenia: a critical review].
    Reine G; Bernard D; Lancon C
    Encephale; 1998; 24(6):530-40. PubMed ID: 9949936
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relapse prevention and recovery in the treatment of schizophrenia.
    Schooler NR
    J Clin Psychiatry; 2006; 67 Suppl 5():19-23. PubMed ID: 16822093
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prediction and prevention of psychosis in youth at clinical high risk.
    Addington J; Heinssen R
    Annu Rev Clin Psychol; 2012; 8():269-89. PubMed ID: 22224837
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Self-rating scales in schizophrenia: assessment of the practical applicability of the Paranoid-Depression Scale (PD-S), the Frankfurt Self-feeling Scale (FBS) and of two visual analogue scales].
    Schaeffer E; Wciórka J
    Psychiatr Pol; 2003; 37(2):315-35. PubMed ID: 12776661
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.